We used a detailed dengue classification to assess the variability in disease severity and outcomes in a cohort of patients classified as “dengue with warning signs” according to the 2009 World Health Organization (WHO) criteria. We describe a wide range of severity and outcomes, which highlights the need and potential to improve the current WHO dengue classification.
3 September 2025 in New Microbes and New Infections
SUMMARY: Dengue fever, a major mosquito-borne viral disease, is transmitted by Aedes mosquitoes and poses a significant global health burden. Despite extensive research, the spatiotemporal dynamics of dengue virus (DENV) lineages in Colombia remain understudied. Here we analyze 11,443 complete genome sequences from Colombia and the Americas to map the genomic epidemiology of DENV-2 and DENV-3. Phylogeographic reconstruction revealed multiple independent introductions and exportations of the DENV-2 II and III lineages, as well as the DENV-3 lineage III C.2, underscoring Colombia’s critical role both as a source and a sink of viral traffic within the Americas. Antigenic profiling demonstrated distinct clustering of emergent lineages in antigenic space, consistent with immune-escape–driven turnover. These results highlight the necessity of sustained, high-resolution genomic surveillance to guide targeted public-health interventions and mitigate dengue transmission across the region.
15 January 2024 in Revista chilena de obstetricia y ginecología
Human T-cell lymphotropic virus type 1 (HTLV-1) affects between 10 and 20 million people worldwide and remains a neglected infection in endemic areas such as southwestern Colombia. This study aimed to describe the clinical and demographic characteristics of forty-four patients with confirmed HTLV-1 infection treated at a referral center between January 2021 and December 2023. A retrospective case series analysis was conducted, including twenty-three pediatric patients, sixteen adults, and five pregnant women, with confirmation by Western Blot. Among the pediatric population, 52.2% presented with anemia, leukocytosis, and pulmonary coinfections, mainly due to Aspergillus spp. and Mycobacterium tuberculosis; 47.8% had infective dermatitis, and 45.5% had malnutrition. In adults, adult T-cell leukemia/lymphoma (ATLL) was the main manifestation (56.3%), followed by neurological involvement (43.7%). The mortality rate among adults was 68.7%, and one death was recorded in the pediatric group. The pregnant women had a mean age of 33 years and an average gestational age of 31.6 weeks at diagnosis; all were asymptomatic carriers. These findings highlight the clinical burden of HTLV-1 across different age groups and reinforce the need to implement public health strategies, including prenatal screening and comprehensive clinical follow-up in endemic areas.
A history of invasive mold disease (IMD) often delays or contraindicates allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. Given the limited data on pediatric patients with pre-allo-HSCT IMD, we aimed to describe the management and clinical outcomes of a cohort of children with IMD prior to allo-HSCT through day +100 post-transplantation. Between 2021 and 2024, ten pediatric patients were identified with proven or probable IMD. Their median age was 8.5 years. The most common pathogens were Aspergillus (n = 5) and Fusarium (n = 4). Infections most frequently involved the lungs followed by paranasal sinuses, bloodstream, liver, and skin. All patients demonstrated clinical improvement before transplantation, and by day +100 post-HSCT, no IMD relapses or infection-related mortality were observed. These findings suggest that complete radiologic or clinical resolution is not a prerequisite for proceeding with transplantation. Recent IMD should not be considered an absolute contraindication to urgent allo-HSCT when clinical improvement is evident, as transplantation facilitates immune reconstitution necessary for definitive infection control.